Our research focused on RNF187 function in human breast cancer, and we discovered that RNF187 functions as an inhibitor of the Hippo/YAP axis, which subsequently inhibits cancer progression in triple-negative breast cancers [27]. Here, RNF187 is linked to triple-negative breast carcinoma.